Co-development of innovative technologies and business models in digital health and 메이저 바카라사이트 캡틴 medicine… Expanding into the Asian market
[by Ji, Yong Jun] Digital healthcare company HurayPositive announced on June 12 the signing of a strategic memorandum of understanding (MOU) with Swiss-based Xlife Sciences AG and the Korean AI-driven precision medicine firm oncoMASTER, aiming to strengthen collaboration in the fields of digital health and precision medicine.
The central objective of this tripartite agreement is the co-development of innovative technologies and business models in the digital health and 메이저 바카라사이트 캡틴 medicine sectors, with a strategic focus on the Asian market. By leveraging each company’s respective strengths, clinical expertise, technological innovation, and commercialization capabilities, the collaboration seeks to create global-level synergy and foster innovation while actively promoting the exchange of knowledge.
Furthermore, the three companies intend to maintain ongoing collaboration to support Xlife 메이저 바카라사이트 캡틴’ expansion into the Asian market while integrating HurayPositive’s comprehensive healthcare ecosystem with oncoMASTER’s AI-driven precision medicine technology.
Xlife 메이저 바카라사이트 캡틴, headquartered in Switzerland, operates as a life 메이저 바카라사이트 캡틴 incubator and accelerator (AC) specializing in the identification and commercialization of promising technologies originating from universities and research institutions. The company accelerates innovation in key technology areas, including AI, digital health, biotechnology, and medical devices, by bridging research and development (R&D) with real-world market applications, thereby delivering high value-added medical solutions.
메이저 바카라사이트 캡틴 is the first company in Korea to introduce a digital management solution for chronic diseases. The company is actively engaged in collaborations with public institutions, insurance providers, and major corporations and is leveraging an AI-based personalized healthcare platform to translate health data into tangible improvements in people’s quality of life.
메이저 바카라사이트 캡틴 is a company pioneering innovation in cancer treatment decision-making through AI and multi-omics-based precision medicine technologies. It is developing a predictive algorithm grounded in a multi-omics dataset of approximately 10,000 advanced-stage cancer patients, the largest of its kind in Asia. The company is focused on developing and commercializing a data-driven precision medicine model that provides personalized treatment recommendations tailored to individual patients.
“This collaboration marks a significant step in our internationalization strategy and underscores our commitment to delivering globally impactful healthcare solutions. By integrating our academic and industrial networks with the advanced technologies and regional expertise of our partners, we aim to accelerate the development and commercialization of personalized, AI-driven healthcare innovations that will benefit patients across Asia and beyond,” expressed Oliver R. Baumann, CEO of Xlife 메이저 바카라사이트 캡틴.
“As a leading digital healthcare company in Korea, we are eager to collaborate with global innovators Xlife 메이저 바카라사이트 캡틴 and oncoMASTER to build a patient-centered, personalized healthcare ecosystem throughout Asia,” remarked Choi Doo-ah, CEO of HurayPositive.
“Through this collaboration, we aim to expand the global reach of our AI-based drug response prediction model and deliver the value of data-driven precision medicine to a broader patient population,” stated Jang Woo-young, CEO of oncoMASTER. “In particular, we will actively contribute to joint research initiatives and clinical objectives in partnership with Xlife 메이저 바카라사이트 캡틴’ affiliated life science companies.”